ISSN 1662-4009 (online)

ey0017.2-2 | Neonatal Hypoglycaemia | ESPEYB17

2.2. Diazoxide-induced pulmonary hypertension in hyperinsulinaemic hypoglycaemia: Recommendations from a multi-centre study in the United Kingdom

SC Chen , A Dastamani , D Pintus , D Yau , S Aftab , L Bath , C Swinburne , L Hunter , A Giardini , G Christov , S Senniappan , I Banerjee , MG Shaikh , P Shah

To read the full abstract: Clin Endocrinol (Oxf). 2019 Dec;91(6):770–775. PMID: 31520536Diazoxide is the first line treatment for patients with hyperinsulinaemic hypoglycaemia (HH). The vast majority of patients tolerate diazoxide well without any major complications. However, diazoxide is known to cause several side effects including hypertrichosis, neutropaenia, thrombocytop...

ey0017.3-14 | Thyroid cancer | ESPEYB17

3.14. Preoperative metabolic classification of thyroid nodules using mass spectrometry imaging of fine-needle aspiration biopsies

RJ DeHoog , J Zhang , E Alore , JQ Lin , W Yu , S Woody , C Almendariz , M Lin , AF Engelsman , SB Sidhu , R Tibshirani , J Suliburk , LS Eberlin

To read the full abstract: Proc Natl Acad Sci U S A. 2019;116:21401–21408.This prospective diagnostic study used desorption electrospray ionization mass spectrometry (DESI-MS) to classify thyroid nodules by their metabolic signature, and more precisely their lipid profile. DESI-MS is a technique using charged aerosols of microdroplets which are sprayed onto a surface (e.g. tissue) to desorb and ionize molecules which are then analyzed by MS...

ey0017.5-7 | Translational Highlights | ESPEYB17

5.7. RANKL Inhibition in fibrous dysplasia of bone: A preclinical study in a mouse model of the human disease

B Palmisano , E Spica , C Remoli , R Labella , A Di Filippo , S Donsante , F Bini , D Raimondo , F Marinozzi , A Boyde , P Robey , A Corsi , M Riminucci

To read the full abstract: J Bone Miner Res. 2019;34(12):2171–2182.In brief: The effect of RANKL inhibition on fibrous dysplasia development is explored here using a mouse model of a fibrous dysplasia-like disorder. Anti-mouse RANKL monoclonal antibody treatment prevented the development and growth of lesions. However, after discontinuation of anti-mouse ...

ey0017.6-17 | Transgender Medicine: Brain and Psychology | ESPEYB17

6.17. Similarity in transgender and cisgender children’s gender development

S Gulgoz , JJ Glazier , EA Enright , DJ Alonso , LJ Durwood , AA Fast , R Lowe , C Ji , J Heer , CL Martin , KR Olson

To read the full abstract: Proc Natl Acad Sci U S A. 2019, Dec 3; 116: 24480-5. doi: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900519/pdf/pnas.201909367.pdfIn a large sample of 317 US American transgender children aged 3–12 years, the authors compared gender outcomes of transgender children with cisgender peers. They also assessed whether the time ...

ey0017.11-12 | Pharmacologic Treatment | ESPEYB17

11.12. A randomized, controlled trial of liraglutide for adolescents with obesity

AS Kelly , P Auerbach , M Barrientos-Perez , I Gies , PM Hale , C Marcus , LD Mastrandrea , N Prabhu , S; NN8022-4180 Trial Investigators Arslanian

To read the full abstract: N Engl J Med. 2020;382(22):2117–2128. doi: https://pubmed.ncbi.nlm.nih.gov/32233338/Kelly et al. randomly assigned (1:1) n =251 obese adolescents (age 12 to <18 years) to receive either liraglutide (3.0 mg), a long-acting glucagon-like peptide-1 agonist, or placebo subcutaneously once daily in addition to lifestyle therapy. Liraglutide w...

ey0017.11-14 | New Insight into Bariatric Surgery | ESPEYB17

11.14. Five-year outcomes of gastric bypass in adolescents as compared with adults

TH Inge , AP Courcoulas , TM Jenkins , MP Michalsky , ML Brandt , SA Xanthakos , JB Dixon , CM Harmon , MK Chen , C Xie , ME Evans , MA Helmrath

To read the full abstract: The New England journal of medicine. 2019;380(22):2136–45.Here, Inge et al. explored whether the outcomes of Roux-en-Y gastric bypass (RYGB) differ according to the age of the patient at the time of surgery. They analysed retrospective data on the 5-year outcomes of RYGB in 161 adolescents from the Teen-LABS-study (1) and in 396 adults with a history...

ey0017.11-15 | New Insight into Bariatric Surgery | ESPEYB17

11.15. 5-year mental health and eating pattern outcomes following bariatric surgery in adolescents: a prospective cohort study

Jarvholm , G Bruze , M Peltonen , C Marcus , CE Flodmark , P Henfridsson , AJ Beamish , E Gronowitz , J Dahlgren , J Karlsson , T Olbers

To read the full abstract: Lancet Child Adolesc Health. 2020;4(3):210–19. PMID 31978372.In this non-randomized matched-control study, 81 obese adolescents undergoing Roux-en-Y gastric bypass surgery (RYGB) who participated in the Adolescent Morbid Obesity Surgery (AMOS) study (11) were compared with 80 obese controls from the Swedish Childhood Obesity Treatment Register (BORIS) who rec...

ey0017.13-3 | Advocacy, History and Society | ESPEYB17

13.3. Effective coverage measurement in maternal, newborn, child, and adolescent health and nutrition: Progress, future prospects, and implications for quality health systems

AD Marsh , M Muzigaba , T Diaz , J Requejo , D Jackson , D Chou , J Cresswell A , R Guthold , A Moran C , K Strong L , A Banerjee , A Soucat

To read the full abstract: Lancet Glob Health 2020; 8: e730–36. doi: 10.1016/S2214-109X(20)30104-2• Sustainable Development Goals (SDG) were adopted by United Nations Member States in 2015. Universal health coverage is at the centre of SDG #3 but lacks metrics that make it possible to assess how effective the provided healthcare is.• WHO and UNICEF convened a group of ...

ey0017.13-8 | Diabetes | ESPEYB17

13.8. Diabetic microvascular complications among children and adolescents in northwestern Tanzania: A cross-sectional study

D Msanga , K Reis , N Kayange , R Bakalemwa , B Kidenya , D Hau , C Mwanansao , D Mahamba , S Ottaru , E Kwiyolecha , R Peck

To read the full abstract: Annals of Global Health. 2020; 86(1): 43, 1–8. doi: https://doi.org/10.5334/aogh.2669• The authors assessed the prevalence of diabetic microvascular complications in 155 children and adolescents with Type 1 diabetes in northwestern Tanzania.• They observed poor diabetes control in 69% of the patients and a high rate of diabetic nephropathy (32.9%), retin...

ey0017.15-8 | (1) | ESPEYB17

15.8. Arginine-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: A prospective diagnostic study

B Winzeler , N Cesana-Nigro , J Refardt , DR Vogt , C Imber , B Morin , M Popovic , M Steinmetz , CO Sailer , G Szinnai , I Chifu , M Fassnacht , M Christ-Crain

To read the full abstract: Lancet. 2019 Aug 17;394(10198):587–595. doi: 10.1016/S0140-6736(19)31255-3.These authors previously described that the measurement of copeptin, a peptide cleaved in the posterior pituitary from the protein precursor of vasopressin and stable in circulation, is an accurate tool to diagnose diabetes insipidus (DI; vasopressin insufficiency). However, the...